The American Society for Radiation Oncology (ASTRO) will host news briefings with accompanying live webcasts on the top cancer research papers from its 51st Annual Meeting to be held this coming week in Chicago. Prostate cancer features in three of briefings. Here are the headlines:

News briefing 1:
Monday, November 2, at 8:00 a.m. (Central); 9:00 a.m. (Eastern)
Study findings previewed:
Four months hormone therapy added to radiation increases survival for medium-risk, but not low-risk, prostate cancer patients (late-breaking study).

News briefing 3
Tuesday, November 3, at 8:00 a.m. (Central); 9:00 a.m. (Eastern)
What: News briefing with live webcast from ASTRO’s 51st Annual Meeting.
Study findings previewed:

Adding proton therapy “boost” to X-ray radiation therapy reduces prostate cancer recurrences.

Proton therapy is well-tolerated in prostate cancer patients.

News briefing 4
Tuesday, November 3, at 12:00 p.m. (Central); 1:00 p.m. (Eastern)
Study findings previewed:

Shorter radiation course stops cancer growth in high-risk prostate cancer patients.

Shorter radiation course as effective as standard therapy for prostate cancer recurrence.